Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Lewy Body Disease

fluorodeoxyglucose f18 has been researched along with Lewy Body Disease in 107 studies

Research

Studies (107)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's21 (19.63)29.6817
2010's58 (54.21)24.3611
2020's28 (26.17)2.80

Authors

AuthorsStudies
Arnaldi, D; Bauckneht, M; Biassoni, E; Brugnolo, A; Chincarini, A; Donegani, MI; Girtler, N; Guerra, UP; Massa, F; Mattioli, P; Morbelli, S; Nobili, F; Orso, B; Pagani, M; Pardini, M; Peira, E; Raffa, S1
Graff-Radford, J; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Whitwell, JL1
Jeong, SH; Lee, PH; Lee, S; Oh, KT; Sohn, YH; Ye, BS; Yoo, HS; Yun, M1
Colloby, SJ; Firbank, MJ; Ingram, M; Lloyd, JJ; O'Brien, JT; Taylor, JP1
Baik, K; Jeon, S; Kang, SW; Lee, PH; Lee, YG; Park, M; Sohn, YH; Ye, BS; Yoon, SH1
Bonanni, L; Da Ronch, C; Fiore, V; Gallucci, M; Grassivaro, F1
Grothe, MJ; Labrador-Espinosa, MA; Mir, P; Moscoso, A; Schöll, M; Silva-Rodríguez, J2
Bouter, C; Hansen, N; Khadhraoui, E; Lange, C; Müller, SJ; Sahlmann, CO; Timäus, C; Wiltfang, J; Woyk, K1
Andersen, KB; Borghammer, P; Brooks, DJ; Danielsen, EH; Gottrup, H; Hansen, AK; Horsager, J; Klit, H; Pavese, N; Poston, KL; Schacht, AC1
Chen, K; Ge, J; Guan, Y; He, Z; Ju, Z; Lin, H; Liu, F; Lu, J; Sun, Y; Wang, M; Wu, P; Zhao, Q; Zuo, C1
Hershey, LA; Lichter, DG1
Feng, LR; Frederiksen, KS; Hasselbalch, SG; Henriksen, OM; Law, I; Mellergaard, C; Vogel, A; Waldemar, G1
Carli, G; de Jong, BM; Ferini-Strambi, L; Galbiati, A; Leenders, KL; Meles, SK; Padovani, A; Perani, D; Pilotto, A; Reesink, FE1
Beretta, L; Caffarra, P; Caminiti, SP; Ferrari-Pellegrini, F; Magnani, G; Perani, D; Santangelo, R1
Belho, ES; Dinand, V; Gupta, V; Mahajan, H; Malik, D; Ranjan, R; Seniaray, N; Verma, R1
Imai, M; Ishibashi, K; Ishii, K; Kanemaru, K; Murayama, S; Nishina, Y; Sakata, M; Sengoku, R; Tago, T; Tanaka, M; Toyohara, J; Wagatsuma, K1
Choi, Y; Chung, SJ; Lee, PH; Lee, S; Lee, YH; Sohn, YH; Ye, BS; Yoo, H; Yun, M1
Iizuka, T; Kameyama, M4
Anderberg, L; Andersen, BB; Bjerregaard, E; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Hejl, AM; Henriksen, OM; Høgh, P; Law, I1
Adam, G; Apostolova, I; Bannas, P; Buchert, R; Frings, L; Grothe, MJ; Klutmann, S; Lange, C; Meyer, PT; Özden, C1
Adachi, H; Ikeda, M; Kanemoto, H; Kazui, H; Nomura, KT; Shimosegawa, E; Wada, T; Yoshiyama, K1
Baroni, M; Bruun, M; Dottorini, ME; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Henriksen, OM; Koikkalainen, J; Law, I; Lötjönen, J; Mecocci, P; Simonsen, AH1
Bourilhon, J; Chastan, M; Danaila, T; Defebvre, L; Derrey, S; Dujardin, K; Gillibert, A; Godefroy, O; Hannequin, D; Houeto, JL; Krystkowiak, P; Lefaucheur, R; Maltête, D; Martinaud, O; Thobois, S; Vera, P; Wallon, D; Welter, ML1
Frings, L; Heimbach, B; Hellwig, S; Meyer, PT1
Baker, MC; Bigio, EH; Buciuc, M; Dickson, DW; Duffy, JR; Flanagan, ME; Franczak, MB; Ghetti, BF; Graff-Radford, J; Graff-Radford, NR; Josephs, KA; Kasanuki, K; Lowe, VJ; Machulda, MM; Parisi, JE; Rademakers, R; Raghunathan, A; Reichard, RR; Ross, OA; Rush, BK; Strand, EA; Whitwell, JL1
Aarsland, D; Arnaldi, D; Bauckneht, M; Beyer, L; Brendel, M; Bruffaerts, R; Camacho, V; Chincarini, A; Davidsson, A; Donegani, MI; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Miceli, A; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, MA; Padovani, A; Pardini, M; Peira, E; Pilotto, A; Raffa, S; Rominger, A; Sambuceti, G; Trost, M; van Berckel, BNM; Vandenberghe, R1
Boeve, BF; Botha, H; Chen, Q; Ferman, TJ; Fields, J; Graff-Radford, J; Graff-Radford, N; Gunte, JL; Jack, CR; Jain, M; Jones, DT; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, VJ; Min, P; Miyagawa, T; Petersen, RC; Przybelski, SA; Savica, R; Schwarz, CG; Senjem, ML1
Aarsland, D; Agudelo-Cifuentes, M; Bauckneht, M; Brendel, M; Bruffaerts, R; Byttner, S; Camacho, V; Chang, JR; Chincarini, A; Davidsson, A; Etminani, K; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Martínez-Sanchis, B; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, M; Padovani, A; Pilotto, A; Ressner, M; Rominger, A; Soliman, A; Stegeran, R; Trost, M; van Berckel, BNM; Vandenberghe, R1
Adriaanse, SM; Booij, J; Depboylu, C; Heinen, L; Höffken, H; Kesper, K; Leenders, KL; Luster, M; Mayer, G; Meles, SK; Oertel, WH; Overeem, S; Pijpers, A; Reesink, FE; Reetz, K; Renken, RJ; Sittig-Wiegand, E; Teune, LK; Vadasz, D; van Laar, T1
Chen, T; Fu, LP; Gao, ZB; Wang, W; Wang, ZF; Xu, BX; Zhao, XL1
Agosta, F; Altomare, D; Arbizu, J; Barthel, H; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Nestor, P; Nobili, F; Orini, S; Rivolta, J; Walker, Z1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Law, I; Nestor, PJ; Nobili, F; Orini, S; Rivolta, J; Walker, Z1
Chen, D; Ge, J; Guo, Q; Jiang, J; Lu, J; Shi, K; Wu, P; Zhang, H; Zhou, H; Zuo, C1
Boeve, BF; Botha, H; Graff-Radford, J; Jack, CR; Jones, DT; Knopman, DS; Lowe, V; Petersen, RC; Senjem, ML; Townley, RA1
Aljuaid, M; Bybel, B; Goertzen, AL; Kang, DY; Katako, A; Kim, SM; Ko, JH; Lee, CS; Levin, D; Shelton, P; Yoon, HJ1
Dombernowsky, NW; Hasselbalch, SG; Law, I1
Larvie, M; Léger, GC; Leverenz, JB; Pillai, JA; Tousi, B; Wu, G1
Huang, HL; Kwok, CSN; Nguyen, MH; Suantio, AM; Teo, DCH1
Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Sato, K1
Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Murayama, N; Ota, K; Sato, K1
Berg, D; Darreh-Shori, T; Liepelt-Scarfone, I; Lithner, CU; Maetzler, W; Reimold, M; Vijayaraghavan, S1
Amtage, F; Bormann, T; Frings, L; Hellwig, S; Kreft, A; Meyer, PT; Spehl, TS; Tüscher, O; Weiller, C1
Dhawan, V; Eidelberg, D; Feigin, A; Gagnon, JF; Holtbernd, F; Ma, Y; Montplaisir, J; Postuma, RB; Soucy, JP; Tang, CC; Vendette, M1
Arai, H; Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Manabe, Y; Murayama, N; Ota, K; Sato, K1
D'Souza, MM; Damle, N; Jaimini, A; Kushwaha, S; Mondal, A; Saw, S; Sharma, R; Tripathi, M1
Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Ota, K; Sato, K1
Balon, HR; Jolepalem, P; Wong, CY; Wu, D1
Boeve, BF; Dickson, DW; Ferman, TJ; Graff-Radford, J; Gunter, JL; Jack, CR; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, VJ; Murray, ME; Petersen, RC; Przybelski, SA; Senjem, ML; Smith, GE1
Al-Faham, Z; Wong, CY; Zein, RK1
Hosokawa, C; Hosono, M; Hyodo, T; Ishii, K; Murakami, T; Sakaguchi, K; Shimamoto, K; Usami, K; Yamazoe, Y1
Chang, CC; Chen, NC; Huang, SH; Jiang, CF; Lee, CC; Lui, CC; Wang, PW1
Bamford, C; Barnett, N; Davison, C; Donaldson, C; Firbank, MJ; Herholz, K; Lloyd, J; O'Brien, JT; Olsen, K; Williams, D1
Barber, R; Barnett, N; Colloby, SJ; Davison, C; Donaldson, C; Firbank, MJ; Herholz, K; Lloyd, J; O'Brien, JT; Olsen, K; Williams, D1
Amtage, F; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C1
Firbank, MJ; Lloyd, J; O'Brien, JT1
Caminiti, SP; Cappa, SF; Cerami, C; Comi, G; Coppi, E; Falini, A; Ferrari, L; Gianolli, L; Iannaccone, S; Magnani, G; Passerini, G; Perani, D; Pinto, P; Santangelo, R1
Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T1
Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Ota, K; Sato, K; Suzuki, M1
Ferini-Strambi, L; Iaccarino, L; Iannaccone, S; Magnani, G; Marelli, S; Perani, D1
Caminiti, SP; Cappa, SF; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Tettamanti, M1
Chu, LW; Ha, J; Lee, SC; Shea, YF1
Brandel, JP; Brefel Courbon, C; Dumas, H; Guedj, E; Lesage, S; Ory Magne, F; Pariente, J; Payoux, P; Peoc'h, K; Puel, M; Saint-Aubert, L; Vital, A1
Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K1
Cho, SG; Choi, KH; Choi, SM; Kang, SR; Kim, BC; Kim, J; Kwon, SY; Song, HC; Song, M1
Miyazawa, N1
Cai, L; Gao, S; Han, T; Ji, Y; Liu, S; Shi, Z; Wang, X; Wang, XD; Wang, Y; Zhou, Y1
de Leon, MJ; De Santi, S; Glodzik, L; Li, Y; Mistur, R; Mosconi, L; Pirraglia, E; Reisberg, B; Switalski, R; Tsui, WH; Wisniewski, T1
Boecker, H; Drzezga, A; Feurer, R; Förstl, H; Granert, O; Häussermann, P; Kurz, A; Perneczky, R1
Best, R; Bradshaw, J; Hopwood, M; Jones, G; Katsifis, A; Lim, SM; Merory, J; Rowe, CC; Saling, M; Villemagne, VL; Woodward, M1
Chiti, A; Clerici, F; Del Sole, A; Lecchi, M; Lucignani, G; Maggiore, L; Mariani, C; Mosconi, L; Pomati, S1
Apostolova, I; Arlt, S; Buchert, R; Jahn, H; Thiele, F; Wenzel, F; Wilke, F; Young, S1
Boecker, H; Ceballos-Baumann, AO; Drzezga, A; Feurer, R; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R; Valet, M1
Baudrexel, S; Diederich, NJ; Eggers, C; Heiss, WD; Hilker, R; Hohmann, C; Kalbe, E; Klein, JC; Vollmar, S; Weisenbach, S1
Carlis, JV; Dysken, MW; Fink, H; Kuskowski, MA; Lee, JT; Lewis, SM; McCarten, JR; McPherson, S; Munch, KR; Pardo, JV; Rottunda, S; Shah, HH; Sheikh, SA; Surerus, C1
Hayashi, M; Miyazawa, N; Nagasaka, T; Shinohara, T1
Arai, H; Fujishiro, H; Higashi, S; Iseki, E; Kasanuki, K; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R1
Claassen, DO; Josephs, KA; Lowe, VJ; Peller, PJ; Petersen, RC1
Lewis, DH; McCue, TJ; Minoshima, S; Toney, LK1
Boeve, BF; Dickson, DW; Ferman, TJ; Jack, CR; Kantarci, K; Knopman, DS; Lowe, VJ; Parisi, JE; Petersen, RC; Przybelski, SA; Senjem, ML; Smith, GE; Weigand, SD1
Arai, H; Fujishiro, H; Furukawa, Y; Higashi, S; Hino, H; Iseki, E; Kasanuki, K; Katsuse, O; Kosaka, K; Minegishi, M; Sato, K; Togo, T; Uchikado, H; Yamamoto, R1
Gao, S; Zhang, B; Zhao, P1
Fujishiro, H; Iseki, E; Kasanuki, K; Murayama, N; Ota, K; Sato, K; Suzuki, M1
Ahnert-Hilger, G; Buchert, R; Dalmau, J; Gomez, A; Harms, L; Höltje, M; Klingbeil, C; Kohler, S; Kopp, U; Maier, N; Probst, C; Prüss, H; Schmitz, D; Schwab, JM; Stoecker, W; Terborg, C; Wandinger, KP1
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH1
Ataka, S; Kawabe, J; Miki, T; Mizuno, K; Mori, H; Shimada, H; Shiomi, S; Takeuchi, J; Wada, Y; Watanabe, Y1
Aalten, P; Adriaanse, SF; Handels, RL; Hoekstra, OS; Lammertsma, AA; Lemstra, AW; Ossenkoppele, R; Pijnenburg, YA; Prins, ND; Scheltens, P; van Berckel, BN; van Buchem, MA; van der Flier, WM; Verbeek, MM; Verhey, FR; Windhorst, AD; Wolfs, CA1
Brooks, DJ; Chaudhuri, KR; Hu, MT; Jarosz, J; Yaguez, L1
Bruecke, T; Knoll, P; Koehn, H; Mirzaei, S; Rodrigues, M1
Hosaka, K; Ishii, K; Mori, E; Mori, T1
An, H; Gilman, S; Giordani, B; Heumann, M; Junck, L; Koeppe, RA; Little, R; Persad, C; Wernette, K1
Albin, RL; Frey, KA; Gilman, S; Heumann, M; Joshi, A; Junck, L; Koeppe, RA; Little, R; Liu, S1
Augustinack, JC; Bacskai, BJ; Dekosky, ST; Freeman, SH; Frosch, MP; Greenberg, SM; Growdon, JH; Hyman, BT; Irizarry, MC; Johnson, KA; Klunk, WE; Mathis, CA; Raymond, SB1
Boecker, H; Diehl-Schmid, J; Drzezga, A; Forstl, H; Haussermann, P; Kurz, A; Perneczky, R1
Ishii, K; Kono, AK; Miyamoto, N; Mori, E; Murase, K; Sofue, K; Soma, T; Yoshikawa, T1
An, YS; Lee, PH; Yong, SW; Yoon, JK1
Boecker, H; Drzezga, A; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R; Wagenpfeil, S1
Carter, SF; Herholz, K; Jones, M1
Boecker, H; Drzezga, A; Förstl, H; Häussermann, P; Kurz, A; Perneczky, R1
Azevedo, JC; Barbirato, GB; Boechat, Y; Cabral, H; Correa, PL; Dohmann, HF; Felix, RM; Manhães, AC; Mendes, MH; Mesquita, CT; Schmidt, GJ; Schmidt, SL; Tolentino, JC1
Arai, H; Hara, S; Higuchi, M; Higuchi, S; Itoh, M; Okamura, N; Sasaki, H; Shin, RW; Tashiro, M; Trojanowski, JQ1
Mayberg, H; New, P; Tatlidil, R1
Arai, H; Higuchi, M; Hu, XS; Itoh, M; Matsui, T; Okamura, N; Sasaki, H; Takeda, A; Tashiro, M1
Hisanaga, K; Iwasaki, Y; Jin, K; Mochizuki, H; Sato, N; Suzuki, H; Tanji, H1

Reviews

4 review(s) available for fluorodeoxyglucose f18 and Lewy Body Disease

ArticleYear
Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9

    Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography

2018
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9

    Topics: Alzheimer Disease; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Prospective Studies

2018
Nuclear medicine imaging in dementia: a practical overview for hospitalists.
    Hospital practice (1995), 2011, Volume: 39, Issue:3

    Topics: Aged; Alzheimer Disease; Amyloid; Dementia; Diagnosis, Computer-Assisted; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Hospitalists; Humans; Lewy Body Disease; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2011
Positron emission tomography imaging in dementia.
    The British journal of radiology, 2007, Volume: 80 Spec No 2

    Topics: Alzheimer Disease; Blood Glucose; Brain; Cognition Disorders; Dementia; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurotransmitter Agents; Positron-Emission Tomography; Radiopharmaceuticals

2007

Trials

5 trial(s) available for fluorodeoxyglucose f18 and Lewy Body Disease

ArticleYear
Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial.
    Neurology, 2021, 02-02, Volume: 96, Issue:5

    Topics: Aged; Basal Nucleus of Meynert; Brain; Cross-Over Studies; Deep Brain Stimulation; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Implantable Neurostimulators; Lewy Body Disease; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Postoperative Complications; Prosthesis Implantation; Radiopharmaceuticals; Sleep; Treatment Outcome

2021
The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:10

    Topics: Aged; Alzheimer Disease; Autopsy; Cocaine; Cohort Studies; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Lewy Body Disease; Male; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Staining and Labeling; Tomography, Emission-Computed, Single-Photon

2009
Impact of molecular imaging on the diagnostic process in a memory clinic.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2013, Volume: 9, Issue:4

    Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Dementia; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; France; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Memory Disorders; Middle Aged; Molecular Imaging; Outpatient Clinics, Hospital; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles; Treatment Outcome

2013
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Experimental neurology, 2005, Volume: 191 Suppl 1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Motor Activity; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests

2005
Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Experimental neurology, 2000, Volume: 162, Issue:2

    Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gene Frequency; Gliosis; Glucose; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Male; Nerve Tissue Proteins; Occipital Lobe; Sensitivity and Specificity; Synucleins; tau Proteins; Tomography, Emission-Computed; Ubiquitins; Visual Cortex

2000

Other Studies

98 other study(ies) available for fluorodeoxyglucose f18 and Lewy Body Disease

ArticleYear
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:4

    Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Reproducibility of Results

2022
Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
    Journal of Alzheimer's disease : JAD, 2022, Volume: 86, Issue:1

    Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Positron-Emission Tomography

2022
Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Brain : a journal of neurology, 2022, 12-19, Volume: 145, Issue:12

    Topics: Brain; Cognition; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron Emission Tomography Computed Tomography

2022
Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.
    Psychiatry research. Neuroimaging, 2022, Volume: 322

    Topics: Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon

2022
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism.
    Annals of neurology, 2022, Volume: 91, Issue:6

    Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Plaque, Amyloid; Positron-Emission Tomography

2022
"Occipital Pole" Sign on 18 F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy : Evidence From the Treviso Dementia (TREDEM) Registry.
    Clinical nuclear medicine, 2022, Sep-01, Volume: 47, Issue:9

    Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Occipital Lobe; Positron-Emission Tomography; Registries

2022
Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023, Volume: 64, Issue:2

    Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Bodies; Lewy Body Disease; Substantia Nigra

2023
Brain
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2023, Volume: 33, Issue:2

    Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies

2023
Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [
    Movement disorders : official journal of the Movement Disorder Society, 2023, Volume: 38, Issue:5

    Topics: Brain; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Bodies; Lewy Body Disease; Positron-Emission Tomography

2023
Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease.
    Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5

    Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Positron-Emission Tomography

2023
Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain : a journal of neurology, 2023, 11-02, Volume: 146, Issue:11

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Bodies; Lewy Body Disease; Positron-Emission Tomography

2023
Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
    Neurology, 2023, 10-10, Volume: 101, Issue:15

    Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Outcome Assessment, Health Care; Positron-Emission Tomography; Prodromal Symptoms

2023
Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies.
    Journal of the neurological sciences, 2023, 08-15, Volume: 451

    Topics: Alzheimer Disease; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography

2023
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    NeuroImage. Clinical, 2023, Volume: 39

    Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Multiple System Atrophy; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography; Synucleinopathies

2023
Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Neuropsychologia, 2019, Volume: 133

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Spatial Processing; Temporal Lobe

2019
Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Nuclear medicine communications, 2019, Volume: 40, Issue:12

    Topics: Atrophy; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Retrospective Studies

2019
Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    Journal of Alzheimer's disease : JAD, 2020, Volume: 73, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain Mapping; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Temporal Lobe

2020
Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Neurobiology of aging, 2020, Volume: 87

    Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine

2020
The Limitation of Evaluating Cingulate Island Sign by SPECTAuthors' Reply.
    Journal of neuropathology and experimental neurology, 2020, 01-01, Volume: 79, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Lewy Body Disease

2020
A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
    Journal of the neurological sciences, 2020, Mar-15, Volume: 410

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography

2020
FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:4

    Topics: Aged; Basal Forebrain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals

2020
Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Journal of neurology, 2020, Volume: 267, Issue:7

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Deep Learning; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Supervised Machine Learning

2020
Thalamic pulvinar metabolism, sleep disturbances, and hallucinations in dementia with Lewy bodies: Positron emission tomography and actigraphy study.
    International journal of geriatric psychiatry, 2020, Volume: 35, Issue:8

    Topics: Actigraphy; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Body Disease; Positron-Emission Tomography; Pulvinar; Sleep; Thalamus

2020
Evaluating 2-[
    NeuroImage. Clinical, 2020, Volume: 27

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon

2020
Intrinsic Alertness Is Impaired in Patients with Nigrostriatal Degeneration: A Prospective Study with Reference to [123I]FP-CIT SPECT and [18F]FDG PET.
    Journal of Alzheimer's disease : JAD, 2020, Volume: 78, Issue:4

    Topics: Aged; Aged, 80 and over; Attention; Brain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Substantia Nigra; Tropanes; Wakefulness

2020
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
    Annals of neurology, 2021, Volume: 89, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aphasia, Primary Progressive; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Language Tests; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals

2021
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021, Volume: 17, Issue:8

    Topics: Age Factors; Aged; Alzheimer Disease; Brain; Educational Status; Europe; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Positron-Emission Tomography

2021
FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
    NeuroImage. Clinical, 2021, Volume: 31

    Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography

2021
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:2

    Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies

2022
FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:10

    Topics: Aged; Analysis of Variance; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon

2017
Metabolic correlate of memory-deficit awareness in dementia with Lewy bodies: Implication in cortical midline structure.
    Psychiatry research. Neuroimaging, 2017, Nov-30, Volume: 269

    Topics: Aged; Aged, 80 and over; Awareness; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Memory Disorders; Middle Aged; Tomography, Emission-Computed, Single-Photon

2017
Multi-modality molecular imaging characteristics of dementia with Lewy bodies.
    The Journal of international medical research, 2018, Volume: 46, Issue:6

    Topics: Aged; Aged, 80 and over; Aniline Compounds; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles

2018
Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control.
    Behavioural neurology, 2018, Volume: 2018

    Topics: Aged; Cerebral Cortex; China; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Nerve Net; Positron-Emission Tomography

2018
    NeuroImage. Clinical, 2018, Volume: 18

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Hydrocephalus, Normal Pressure; Lewy Body Disease; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2018
Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.
    Scientific reports, 2018, 09-05, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Machine Learning; Male; Middle Aged; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Support Vector Machine

2018
[Confusion, loss of consciousness and unspecific visual hallucinations may be symptoms of dementia with Lewy bodies].
    Ugeskrift for laeger, 2018, Sep-17, Volume: 180, Issue:38

    Topics: Aged, 80 and over; Confusion; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Body Disease; Positron-Emission Tomography; Unconsciousness

2018
Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Parkinsonism & related disorders, 2019, Volume: 64

    Topics: Aged; Alzheimer Disease; Amygdala; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies

2019
FDG-PET in suspected dementia with Lewy bodies: a case report.
    BMC geriatrics, 2019, 05-28, Volume: 19, Issue:1

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Temporal Lobe

2019
The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2019, Volume: 29, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon

2019
A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies.
    Journal of the neurological sciences, 2013, Nov-15, Volume: 334, Issue:1-2

    Topics: Aged; Aged, 80 and over; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Neuroimaging; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Prodromal Symptoms; Prognosis; Radionuclide Imaging; Visual Cortex; Wechsler Scales

2013
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014, Volume: 10, Issue:5

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Apolipoproteins E; Biomarkers; Brain; Carbon Radioisotopes; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles

2014
Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery.
    Brain and language, 2013, Volume: 127, Issue:2

    Topics: Aged; Cognition Disorders; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Learning; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Semantics; Tauopathies

2013
Abnormal metabolic network activity in REM sleep behavior disorder.
    Neurology, 2014, Feb-18, Volume: 82, Issue:7

    Topics: Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lewy Body Disease; Middle Aged; Multimodal Imaging; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; REM Sleep Behavior Disorder; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2014
Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2014, Volume: 14, Issue:1

    Topics: Brain; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals

2014
Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    The neuroradiology journal, 2014, Volume: 27, Issue:1

    Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed

2014
Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    International journal of geriatric psychiatry, 2015, Volume: 30, Issue:3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Hallucinations; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography

2015
Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
    Journal of nuclear medicine technology, 2014, Volume: 42, Issue:3

    Topics: Aged, 80 and over; Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Nortropanes; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2014
Dementia with Lewy bodies: basis of cingulate island sign.
    Neurology, 2014, Aug-26, Volume: 83, Issue:9

    Topics: Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies

2014
18F-FDG PET assessment of Lewy body dementia with cerebellar diaschisis.
    Journal of nuclear medicine technology, 2014, Volume: 42, Issue:4

    Topics: Aged; Cerebellum; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Memory Disorders; Positron-Emission Tomography

2014
Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.
    Annals of nuclear medicine, 2015, Volume: 29, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals; Thiazoles

2015
Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:1

    Topics: Aged; Aged, 80 and over; Cerebral Cortex; Corpus Striatum; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Tropanes

2015
18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:12

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Perfusion; Positron-Emission Tomography; Prospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

2014
An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy.
    The British journal of psychiatry : the journal of mental science, 2016, Volume: 208, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Evidence-Based Practice; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Temporal Lobe

2016
18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:10

    Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lewy Body Disease; Male; Middle Aged; Movement Disorders; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Survival Analysis

2015
The relationship between hallucinations and FDG-PET in dementia with Lewy bodies.
    Brain imaging and behavior, 2016, Volume: 10, Issue:3

    Topics: Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Psychiatric Status Rating Scales; Radiopharmaceuticals; Tomography, X-Ray Computed; Visual Pathways

2016
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; tau Proteins

2016
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12

    Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals

2015
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Psychiatry research. Neuroimaging, 2016, Mar-30, Volume: 249

    Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon

2016
Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.
    Journal of Alzheimer's disease : JAD, 2016, 04-05, Volume: 52, Issue:3

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; REM Sleep Behavior Disorder; Retrospective Studies; Self Report; Statistics, Nonparametric; tau Proteins

2016
Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Annals of nuclear medicine, 2016, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Atrophy; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Temporal Lobe; Tomography, Emission-Computed, Single-Photon

2016
Metabolic connectomics targeting brain pathology in dementia with Lewy bodies.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:4

    Topics: Acetylcholine; Aged; alpha-Synuclein; Brain; Connectome; Databases, Factual; Dopamine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies

2017
Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2016, Volume: 22, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thiazoles

2016
Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.
    BMC neurology, 2016, Jul-30, Volume: 16

    Topics: 14-3-3 Proteins; Adult; Brain; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Delusions; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinsonian Disorders; Positron-Emission Tomography

2016
Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Journal of the neurological sciences, 2016, Oct-15, Volume: 369

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Visual Cortex

2016
Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia.
    Medicine, 2016, Volume: 95, Issue:49

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Chi-Square Distribution; Cohort Studies; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Body Disease; Positron-Emission Tomography; Republic of Korea; Retrospective Studies; ROC Curve

2016
Creutzfeldt-Jakob Disease Mimicking Alzheimer Disease and Dementia With Lewy Bodies-Findings of FDG PET With 3-Dimensional Stereotactic Surface Projection.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:5

    Topics: Aged; Alzheimer Disease; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals

2017
Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies.
    PloS one, 2017, Volume: 12, Issue:3

    Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Biological Transport; Brain; China; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Thiazoles

2017
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Brain; Cognition Disorders; Dementia, Vascular; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lewy Body Disease; Male; Positron-Emission Tomography

2009
Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Blood Glucose; Brain; Cognition; Dementia; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis

2009
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2009, Volume: 53, Issue:6

    Topics: Aged; Amnesia; Automation; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Temporal Lobe

2009
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    NeuroImage, 2010, Apr-15, Volume: 50, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain; Computer Simulation; Dementia; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Models, Statistical; Neurodegenerative Diseases; Positron-Emission Tomography; ROC Curve; Signal Processing, Computer-Assisted

2010
Metabolic alterations associated with impaired clock drawing in Lewy body dementia.
    Psychiatry research, 2010, Feb-28, Volume: 181, Issue:2

    Topics: Aged; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Space Perception

2010
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Neurology, 2010, Mar-16, Volume: 74, Issue:11

    Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Bodies; Lewy Body Disease; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography

2010
Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 years.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2010, Volume: 6, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results

2010
Hypermetabolism in patients with dementia with Lewy bodies.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:7

    Topics: Aged; Aged, 80 and over; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography

2010
Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2010, Volume: 10, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Dominance, Cerebral; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Heart; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iodine Radioisotopes; Lewy Body Disease; Male; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Statistics as Topic; Sympathetic Nervous System; Temporal Lobe

2010
Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:3

    Topics: Aged; Amyloid; Aniline Compounds; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Thiazoles; Tomography, X-Ray Computed

2011
Multimodality imaging characteristics of dementia with Lewy bodies.
    Neurobiology of aging, 2012, Volume: 33, Issue:9

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography; ROC Curve; Statistics, Nonparametric; Thiazoles

2012
Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
    Journal of the neurological sciences, 2012, Mar-15, Volume: 314, Issue:1-2

    Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Autopsy; Brain; Cell Count; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins

2012
18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Parkinsonism & related disorders, 2012, Volume: 18 Suppl 1

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Syndrome

2012
Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
    International journal of geriatric psychiatry, 2012, Volume: 27, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Visual Cortex

2012
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
    Neurology, 2012, May-29, Volume: 78, Issue:22

    Topics: Adrenal Cortex Hormones; Aged; Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Atrophy; Autoimmunity; Biomarkers; Blotting, Western; Cognition Disorders; Cyclophosphamide; Disease Progression; Electrophysiology; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Immunoglobulin A; Immunohistochemistry; Immunotherapy; Lewy Body Disease; Magnetic Resonance Imaging; Neurons; Plasma Exchange; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, N-Methyl-D-Aspartate; Rituximab; Synapses; Temporal Lobe; Treatment Outcome

2012
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Neurology, 2012, Sep-25, Volume: 79, Issue:13

    Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2012
Clinical features of Pittsburgh compound-B-negative dementia.
    Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Case-Control Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins; Thiazoles

2012
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Adult; Aged; Black People; Brain; Cerebral Cortex; Corpus Striatum; Cross-Cultural Comparison; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; India; Lewy Body Disease; London; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinsonian Disorders; Radiography; Radionuclide Imaging; Supranuclear Palsy, Progressive; West Indies; White People

2002
Metabolic impairment of brain metabolism in patients with Lewy body dementia.
    European journal of neurology, 2003, Volume: 10, Issue:5

    Topics: Aged; Aged, 80 and over; Brain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Tomography, Emission-Computed

2003
Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies.
    Annals of nuclear medicine, 2004, Volume: 18, Issue:5

    Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Iofetamine; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2004
11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbon Radioisotopes; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; Regression Analysis; Tetrabenazine

2005
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
    Archives of neurology, 2007, Volume: 64, Issue:3

    Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Autopsy; Brain; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles

2007
Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study.
    Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6

    Topics: Aged; Blood Glucose; Brain; Brain Mapping; Case-Control Studies; Dementia; Educational Status; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recruitment, Neurophysiological

2007
Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:5

    Topics: Aged; Alzheimer Disease; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals

2007
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    European journal of neurology, 2007, Volume: 14, Issue:12

    Topics: Aged; Aged, 80 and over; Brain Mapping; Cerebral Cortex; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity

2007
Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies.
    Neurobiology of aging, 2009, Volume: 30, Issue:9

    Topics: Aged; Cognition Disorders; Delusions; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Hallucinations; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Regression Analysis; Sensitivity and Specificity

2009
Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.
    Dementia and geriatric cognitive disorders, 2008, Volume: 25, Issue:6

    Topics: Aged; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hallucinations; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe; Visual Cortex

2008
Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals

2008
FDG positron emission tomography in diffuse Lewy body disease: a case report.
    Clinical nuclear medicine, 2000, Volume: 25, Issue:12

    Topics: Brain; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed

2000
[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 2001, Volume: 25, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Nuclear Family; Occipital Lobe; Pedigree; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed

2001
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease.
    Journal of neurology, 2001, Volume: 248, Issue:10

    Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed

2001